MALE CONTRACEPTION UPDATE

November 2007
Volume 2, Issue 11

Summaries of new peer-reviewed publications

Binding / fusion targets
“Antisera to recombinant human ESP inhibited both oolemmal binding and fusion of human sperm in the hamster/egg penetration assay (HEPA). The results indicate that ESP is a human alloantigen involved in sperm/egg binding and fusion.”
Equatorial Segment Protein (ESP) is a Human Alloantigen Involved in Sperm-Egg Binding and Fusion.
Wolkowicz MJ, Digilio L, Klotz K, Shetty J, Flickinger CJ, Herr JC.
J Androl. 2007 Oct 31; [Epub ahead of print]
PMID: 17978344

Motility target supporting research
Flagellar CrPKD2 (Chlamydomonas reinhardtii PKD2, a protein with the characteristics of PKD2 family members) “increased fourfold during gametogenesis, and several CrPKD2 RNA interference strains showed defects in flagella-dependent mating. These results suggest that the CrPKD2 cation channel is involved in coupling flagellar adhesion at the beginning of mating to the increase in flagellar calcium required for subsequent steps in mating.”
Function and dynamics of PKD2 in Chlamydomonas reinhardtii flagella.
Huang K, Diener DR, Mitchell A, Pazour GJ, Witman GB, Rosenbaum JL.
J Cell Biol. 2007 Nov 5;179(3):501-14.
PMID: 17984324

“Although [extracellular] ATP did not affect acrosomal exocytosis or protein tyrosine phosphorylation in sperm from healthy donors, it significantly altered several motility parameters, with the largest effects manifested in increased curvilinear velocity and percentage hyperactivation.”
Effects of extracellular adenosine 5'-triphosphate on human sperm motility.
Edwards SE, Buffone MG, Knee GR, Rossato M, Bonanni G, Masiero S, Ferasin S, Gerton GL, Moss SB, Williams CJ.
Reprod Sci. 2007 Oct;14(7):655-66.
PMID: 18000227

“Here we show for the first time that in addition to expression in the Sertoli-Sertoli tight junctions in the seminiferous tubules, the approximately 32 kDa murine JAM-A is present in elongated spermatids and in the plasma membrane of the head and flagellum of sperm. Deletion of Jam-A, using the gene trap technology, results in flagellar defects at the ultrastructural level. In Jam-A-deficient mice, which have reduced litter size, both progressive and hyperactived motility are significantly affected (P<0.0001) before and, more severely, after capacitation.”
JAM-A is present in mammalian spermatozoa where it is essential for normal motility.
Shao M, Ghosh A, Cooke VG, Naik UP, Martin-Deleon PA.
Dev Biol. 2007 Oct 23; [Epub ahead of print]
PMID: 18022613

“Carnitine and acetylcarnitine are important for the acquisition of motility and maturation of spermatozoa in the epididymis… We conclude that both Na(+)-dependent and -independent carnitine transporters, [carnitine/organic cation transporters] OCTN2 and OCTN3, mediate the supply of carnitine and acetylcarnitine to epididymal spermatozoa in mice.”
Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa.
Kobayashi D, Tamai I, Sai Y, Yoshida K, Wakayama T, Kido Y, Nezu J, Iseki S, Tsuji A.
Reproduction. 2007 Nov;134(5):651-8.
PMID: 17965255

“The cell immobilizing system proposed, associated with the microspectrofluorimetric analysis supported by videoimaging, is a simple, rapid and useful tool for those studies having the goal of correlating the presence and cellular distribution of ion channels with their functional status and their response to physiologic and/or pharmacological molecules.”
A semi-immobilizing system associated with microspectrofluorimetric and videoimaging analysis for intracytoplasmic calcium measurement in individual viable spermatozoa.
Micera E, Albrizio M, Surdo NC, Zarrilli A.
J Biotechnol. 2008 Jan 1;133(1):90-5. Epub 2007 Sep 25.
PMID: 17964676

“Our results suggest that a significant proportion of men investigated for male infertility may be epididymal protein P34H deficient.”
Epididymal P34H protein deficiency in men evaluated for infertility.
Moskovtsev SI, Jarvi K, Legare; C, Sullivan R, Mullen JB.
Fertil Steril. 2007 Nov;88(5):1455-7. Epub 2007 Apr 16.
PMID: 17434498

Endocrinological approach supporting research
“We show that in mice with a unique hypomorphic androgen mutation, which disrupts the feedback loop governing T synthesis, that genes involved in cholesterol biosynthesis/uptake and steroid biosynthesis are upregulated. We identify LH as the central regulatory molecule that controls both steroidogenesis and Leydig cell cholesterol homeostasis in vivo… We show T-signaling can affect the synthesis of steroids and modulates the expression of genes involved in de novo cholesterol synthesis.”
Hormonal Regulation of Testicular Steroid and Cholesterol Homeostasis.
Eacker SM, Agrawal N, Qian K, Dichek HL, Gong EY, Lee K, Braun RE.
Mol Endocrinol. 2007 Nov 21; [Epub ahead of print]
PMID: 18032697

“In addition to their well-known pathways of action, both [FSH and Testosterone] have recently been recognized to have new signaling routes that are linked to the Ca (2+) ion, including, among others, the regulation of cell proliferation by FSH and the regulation of cell migration by testosterone.”
Diverse FSH and Testosterone Signaling Pathways in the Sertoli Cell.
Loss ES, Jacobus AP, Wassermann GF.
Horm Metab Res. 2007 Nov;39(11):806-12.
PMID: 17992635

Patients’ and clinicians’ experience with an oral formulation of T in hypogonadal men. “The study was performed in 43 centres in Austria and a dosage of oral testosterone undecanoate of 2x80 mg/day was used for three months… average treatment duration was 13.9 +/- 2.2 weeks. Serum testosterone level increased by more than 50% from 8.7 +/- 4.3 nmol/L to 13.2 +/- 6.7 nmol/L (p < 0.001)… There were no significant effects on serum PSA levels.”
Clinical experience with Andriol(R) Testocaps(R)- The first Austrian surveillance study on the treatment of late-onset hypogonadism.
Jungwirth A, Plas E, Geurts P.
Aging Male. 2007 Dec;10(4):183-7.
PMID: 18033627

“It is suggested that FSH- and testosterone-stimulated tPA expression in Sertoli cells may be via PKA and ERK signal transduction… This study further suggests that testosterone-induced tPA activity in the Sertoli cells might be related to the function of blood-testis barrier opening and/or closing.”
Testosterone upregulation of tissue type plasminogen activator expression in Sertoli cells: tPA expression in Sertoli cells.
Guo J, Shi YQ, Yang W, Li YC, Hu ZY, Liu YX.
Endocrine. 2007 Aug;32(1):83-9. Epub 2007 Oct 9.
PMID: 17992606

Retinoic acid receptor approach
Are the effects of retinoids in vitamin A deficient mice “the result of a direct action on germ cells or are [they] indirectly mediated through Sertoli cells”? “In the absence of feeder cells, RA (retinoic acid) directly induces the transition of undifferentiated spermatogonia to differentiating spermatogonia by stimulating Stra8 and Kit gene expression [and] RA dramatically stimulates Stra8 expression in undifferentiated spermatogonia but has a lesser impact in differentiating spermatogonia…”
Expression of Stimulated by Retinoic Acid Gene 8 (Stra8) and Maturation of Murine Gonocytes and Spermatogonia Induced by Retinoic Acid In Vitro.
Zhou Q, Li Y, Nie R, Friel P, Mitchell D, Evanoff RM, Pouchnik D, Banasik B, McCarrey JR, Small C, Griswold MD.
Biol Reprod. 2007 Nov 21; [Epub ahead of print]
PMID: 18032419

Review
Dr. John Amory reviews “the drugs that are known to adversely impact spermatogenesis, and/or sperm function and detail what is known about the mechanisms through which these compounds impair fertility in men.”
Drug effects on spermatogenesis.
Amory JK.
Drugs Today (Barc). 2007 Oct;43(10):717-24.
PMID: 17987224

Proteomic / genomic supporting research
“[These] data suggest that GDNF induces CREB/ATF-1 family member phosphorylation and c-fos transcription via the Ras/ERK1/2 pathway to promote the proliferation of SSC. Unveiling GDNF signaling cascades in SSC has important implications in providing attractive targets for male contraception as well as for the regulation of stem cell renewal Vs. differentiation.”
GDNF Up-regulates c-fos Transcription via the Ras/ERK1/2 Pathway to Promote Mouse Spermatogonial Stem Cell Proliferation.
He Z, Jiang J, Kokkinaki M, Golestaneh N, Hofmann MC, Dym M.
Stem Cells. 2007 Oct 25; [Epub ahead of print]
PMID: 17962702

“[Initial] testis development is normal in Etv5(-/-) mice despite decreased body weight, but spermatogonial stem cell (SSC) loss begins between 4 and 8d of age, indicating that ETV5 has effects beginning in the early neonatal period. Etv5(-/-) mice are infertile even when sperm is produced, indicating that ETV5 loss has other effects besides lack of SSC self-renewal that impair fertility.”
Effects of ETV5 (Ets Variant Gene 5) on Testis and Body Growth, Time Course of Spermatogonial Stem Cell Loss, and Fertility in Mice.
Schlesser HN, Simon L, Hofmann MC, Murphy KM, Murphy T, Hess RA, Cooke PS.
Biol Reprod. 2007 Nov 21; [Epub ahead of print]
PMID: 18032421

“The [ubiquitin-specific protease 26] USP26 gene might be of importance in male reproduction. Mutations in this gene might be associated with male infertility, and might negatively affect testicular function. Further research on this issue is in progress.”
Novel mutations in ubiquitin-specific protease 26 gene might cause spermatogenesis impairment and male infertility.
Zhang J, Qiu SD, Li SB, Zhou DX, Tian H, Huo YW, Ge L, Zhang QY.
Asian J Androl. 2007 Nov;9(6):809-14.
PMID: 17968467

Return to the top

Stay in touch with the Coalition

Each month Kirsten Thompson of the International Male Contraception Coalition spends hours reviewing over 40 journals to bring you succinct summaries of the latest research. IMCC also works with the Male Contraception Information Project to bring you policy developments and, occasionally, even juicy gossip! You can do your part by making sure you contact IMCC when you have news you'd like your colleagues to hear about. Got an opening in your lab? Tried a research approach that met with success – or, on the contrary, turned out to be a big waste of time? Let us know! We're here to keep the male contraception community in touch and moving forward together. Next month IMCC will launch a new set of tools to help strengthen this network. Stay tuned.

Return to the top

Male contraceptives in the press

Are blokes in Australia interested in the subject of male contraception? You bet! This short opinion piece on attitudes towards vasectomy and a potential "male Pill" had received a whopping 329 comments at last count, and they make for enlightening reading on the range of human experience and attitudes (more enlightening than the original article, which doesn't convey the pros and cons of vasectomy or a male Pill particularly accurately). Read this one to see what your end-users are thinking and worrying about when they pick a method.
Contraception: Too old for condoms?
Sydney Morning Herald, 8 November

Editorial says men and women need to speak up if they want new contraceptive options. “Times continue to change and more research is being done in the field of male contraception, but for many of us women, this is too little, too late.”
Male birth control: A hard pill to swallow
La Voz Weekly, 9 November

“Some researchers attending a pharmaceutical convention in San Diego believe the future of male contraception may come in a pill form…” Dr. Jim Dalton is briefly interviewed on television about selective androgen receptor modulator (SARM) contraceptive development.
Male Birth-Control Pill Closer To Reality (and a video clip)
NBC San Diego, 13 November

The Chinese filter-core Intra Vas Device (IVD) in the Indian press. According to this article, clinical trials have now included over 1600 men, and approval is hoped for in 2008. The article compares the demographic situations in India and China: “Demographers expect India’s population to keep soaring until at least 2050, negating any effect of GDP growth on the quality of life of the masses.”
Long way to go for China's new birth control technique?
Merinews of New Delhi, 19 November

Dr. Joseph Hall’s enzyme mimic male contraceptive approaches clinical trials. “Hall said he is focusing on creating a synthetic compound that disrupts the function of the sperm rather than eliminates them. He is targeting an enzyme that sperm use to detect and fertilize the egg.” Hall hopes to be recruiting volunteers within 3 years.
It's conceivable
Daily Press of Newport News, 19 November

A successful injection plus implant formulation of a male hormonal contraceptive is being shelved in Australia. Despite compelling research showing a demand by couples for the drug, Anzac Institute Professor David Handelsman said the contraceptive was viewed as an orphan medication in the same category as AIDS and tuberculosis drugs. "The really unfortunate situation is there is a demand for something that works - we are waiting for a smaller company in India or China to take it up," Professor Handelsman said. "It's something we are proud of."
Male contraceptive at risk of being orphaned
The Daily Telegraph, 22 November

More coverage of Dr. Jim Dalton ’s selective androgen receptor modulator development. “GTX' male contraceptive, on the other hand, has promising potential for the 21st Century man, according to GTX preclinical R&D vice president James Dalton…”
Men get the heads up on possible oral contraceptive
DrugResearcher.com, 23 November

Return to the top

Calendar of events

Planning to attend a male contraception or andrology-related event that's not listed here? Let us know so we can post it and alert your colleagues to interesting upcoming events.

2008
January 1
Deadline for European Society of Contraception abstract submission
February 1
Deadline for ESHRE meeting abstract submission
April 12-15
33rd Annual Conference of the American Society of Andrology; Albuquerque, NM, USA
April 30 - May 3
10th Congress of the European Society of Contraception; Prague, Czech Republic
May 2-7
Joint meeting of the 15th European Testis Workshop and the Nordic Association for Andrology; Naantali, Finland
May 3-7
10th European Congress of Endocrinology; Berlin, Germany
May 15
Deadline for ASRM meeting abstract submission
May 26-28
1st World Congress on Reproductive Biology; Kona, HI, USA
July 6-9
European Society for Human Reproduction and Embryology 24th Annual Meeting; Barcelona, Spain
July 6-11
Gordon Research Conferences – Ion Channels; Tilton, NH, USA
August 3-8
Gordon Research Conferences – Reproductive Tract Biology; Andover, NH, USA
September 26
World Contraception Day
November 8-12
American Society for Reproductive Medicine 64th Annual Meeting; San Francisco, CA, USA

 

Return to the top

Editors

Kirsten Thompson, Director of the Male Contraception Coalition (MCC)
Email: Kirsten@MaleContraceptives.org
Phone: +1 (443) 858-1183

Elaine Lissner, Director of the Male Contraception Information Project (MCIP)
Email: Lissner@NewMaleContraception.org
Phone: +1 (415) 863-1859 x107